Search details
1.
[68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation.
Eur J Nucl Med Mol Imaging
; 2024 Apr 30.
Article
in English
| MEDLINE | ID: mdl-38687372
2.
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study.
World J Surg Oncol
; 21(1): 192, 2023 Jun 27.
Article
in English
| MEDLINE | ID: mdl-37370080
3.
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study.
Int J Mol Sci
; 24(23)2023 Nov 21.
Article
in English
| MEDLINE | ID: mdl-38068896
4.
Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia.
Medicina (Kaunas)
; 58(8)2022 Aug 17.
Article
in English
| MEDLINE | ID: mdl-36013579
5.
Adrenocortical carcinoma: current treatment options.
Curr Opin Oncol
; 33(1): 16-22, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33186181
6.
Outcome and genetic analysis of patients affected by retinal capillary hemangioblastoma in von Hippel Lindau syndrome.
Mol Vis
; 27: 542-554, 2021.
Article
in English
| MEDLINE | ID: mdl-34566400
7.
SDHx and Non-Chromaffin Tumors: A Mediastinal Germ Cell Tumor Occurring in a Young Man with Germline SDHB Mutation.
Medicina (Kaunas)
; 56(11)2020 Oct 25.
Article
in English
| MEDLINE | ID: mdl-33113876
8.
Correction: Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study.
World J Surg Oncol
; 21(1): 298, 2023 Sep 19.
Article
in English
| MEDLINE | ID: mdl-37723531
9.
The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated Paragangliomas.
Neuroendocrinology
; 105(4): 384-393, 2017.
Article
in English
| MEDLINE | ID: mdl-28122379
10.
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).
Mod Pathol
; 28(6): 807-21, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25720320
11.
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study.
Lancet Oncol
; 15(6): 648-55, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24745698
12.
Anatomical and functional changes of the fetal adrenal gland in intrauterine growth restriction.
Int J Gynaecol Obstet
; 2024 Mar 26.
Article
in English
| MEDLINE | ID: mdl-38532440
13.
The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal gland.
Sci Rep
; 14(1): 8044, 2024 04 05.
Article
in English
| MEDLINE | ID: mdl-38580769
14.
Tumour microenvironment in pheochromocytoma and paraganglioma.
Front Endocrinol (Lausanne)
; 14: 1137456, 2023.
Article
in English
| MEDLINE | ID: mdl-37033265
15.
The aggressiveness of succinate dehydrogenase subunit B-deficient chromaffin cells is reduced when their bioelectrical properties are restored by glibenclamide.
Endocr Relat Cancer
; 30(10)2023 10 01.
Article
in English
| MEDLINE | ID: mdl-37493200
16.
Intratumour microbiota modulates adrenocortical cancer responsiveness to mitotane.
Endocr Relat Cancer
; 30(10)2023 10 01.
Article
in English
| MEDLINE | ID: mdl-37695690
17.
Prognostic Value of Microscopic Tumor Necrosis in Adrenal Cortical Carcinoma.
Endocr Pathol
; 34(2): 224-233, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-36952130
18.
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy.
Front Endocrinol (Lausanne)
; 14: 1320722, 2023.
Article
in English
| MEDLINE | ID: mdl-38269251
19.
New Findings on Presentation and Outcome of Patients With Adrenocortical Cancer: Results From a National Cohort Study.
J Clin Endocrinol Metab
; 108(10): 2517-2525, 2023 09 18.
Article
in English
| MEDLINE | ID: mdl-37022947
20.
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study.
Lancet Diabetes Endocrinol
; 11(10): 720-730, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37619579